Med BioGene
Med BioGene, Helomics Revise Licensing Agreement
The firms have eliminated several terms of their original deal and have cross-licensed IP to allow Med BioGene to license Gene FX Lung to other firms.
Med BioGene Poised to take Precision Therapeutics to Arbitration over Milestone Payment
NEW YORK (GenomeWeb) – Med BioGene today announced that it is ready to initiate proceedings against its commercial partner Precision Therapeutics to enforce a C$1 million (US$920,000) milestone payment due to Med BioGene.
Precision Therapeutics CLIA-Certified to Offer Med BioGene's GeneFx Lung Assay
NEW YORK (GenomeWeb News) – Med BioGene today said that its commercial partner, Precision Therapeutics, has been certified to perform Med BioGene's lung cancer test out of Precision's Pittsburgh laboratory.
Signal Genetics Drops Legal Action against Med BioGene, Precision Therapeutics
NEW YORK (GenomeWeb News) – Signal Genetics and its subsidiary Respira Health have withdrawn and dismissed their lawsuit against Med BioGene and its commercial partner Precision Therapeutics.
In Brief This Week: Life Technologies; PerkinElmer; Agilent; Activiomics, KHK; Cancer Genetics, Roche Servicios; More
NEW YORK (GenomeWeb News) – Life Technologies said this week that it has opened up a 'Customer Experience Centre' in Russia in collaboration with one of its distributors, Khimexpert.
May 30, 2013
Med BioGene Reports No Revenues in Q1; Loss Narrows
May 30, 2012
Med Biogene Records Loss of US$117K in Q1
Nov 30, 2011
Med BioGene Posts $1.7M in Revenues for Q3
Aug 30, 2011
Med BioGene Records $594K in H1 2011 Revenues
Jun 29, 2011